New peritoneal dialysis diagnostic discovered

Oct 17, 2007

Thanks to a discovery by scientists at Robarts Research Institute and The University of Western Ontario, patients undergoing peritoneal dialysis may soon be able to worry less about the risks of infection and lessen their hospital stays.

Peritoneal dialysis, which involves placing a tube into the peritoneal cavity, allows people who have suffered from kidney failure to carry on a relatively normal life; however, complications include high incidence of infection of the abdominal cavity, known as peritonitis, which most patients experience every year or so.

Led by Joaquin Madrenas, Robarts scientist and Canada Research Chair in Immunobiology at Western, the study has looked at the molecule RIP2 (receptor-interacting protein 2) for clues over the past three years. Though the precise function of RIP2 is not yet known, scientists made the important finding that levels of the molecule increase during infection. More importantly, peritoneal dialysis patients with peritonitis who have high levels of RIP2 can be sent home and treated with antibiotics. If RIP2 levels do not go up, patients risk a protracted infection and should be admitted for closer monitoring and more intense treatment. This information can be used to address the need to admit patients to the hospital.

“We currently have no objective indicator if peritonitis will be really bad, so we tend to try to guess how bad it is,” says Madrenas. “What we have found is that, by monitoring RIP2, we can predict the outcome of the infection in patients taking part in peritoneal dialysis.”

By keeping patients out of hospitals, this discovery not only helps improve quality of life, but also reduces strain on the healthcare system.

The team, which includes Madrenas’ PhD student Michelle McCully and a close collaboration with Dr. Peter Blake of the division of nephrology at Western, will now try to adapt the discovery to a clinical laboratory and hopefully develop a diagnostic test that can be conducted with a patient’s peritoneal fluid on a routine basis. Madrenas also wonders if there are other factors preventing RIP2 levels from increasing in some patients. “If we know what problem is preventing this increase, we could fix it and possibly prevent infections,” he says.

Source: University of Western Ontario

Explore further: The 'fifth taste,' umami, could be beneficial for health

add to favorites email to friend print save as pdf

Related Stories

Kennewick Man's DNA likely that of a Native

8 hours ago

Nearly two decades after the ancient skeleton called Kennewick Man was discovered on the banks of the Columbia River, the mystery of his origins appears to be nearing resolution.

Hewlett-Packard introduces eight new business tablets

8 hours ago

Hoping to give a boost to its mobile-computing business, Hewlett-Packard unveiled eight new tablets and related products Tuesday aimed at educators, retailers, health care workers and other professionals.

Recommended for you

Medical radiation may be reduced to one-sixth

59 minutes ago

One of this century's most significant mathematical discoveries may reduce the number of measuring points to one-sixth of the present level. This means reduced exposure to radiation and faster medical imaging ...

The 'fifth taste,' umami, could be beneficial for health

14 hours ago

The umami taste could have an important and beneficial role in health, according to research published in the open access journal Flavour. The journal's special series of articles 'The Science of Taste' also finds that ' ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.